Literature DB >> 16198134

Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis.

Z Jarkovská1, M Hodková, M Sazamová, M Rosická, S Dusilová-Sulková, J Marek, V Justová, Z Lacinová, M Haluzík, T Haas, M Krsek.   

Abstract

Ghrelin was originally isolated from the rat stomach and significant amounts were found also in the kidney. Present study was designed to examine changes in ghrelin levels in renal failure and their relationship to the GH/IGF-I axis. Fourty patients with mild-to-severe CRF (19 men, 21 women, aged 62.5 +/- 2.2 years, BMI 27.57 +/- 0.73 kg/m(2)) and 34 healthy control subjects (17 men, 17 women, aged 60 +/- 2.6 years, BMI 27.55 +/- 0.79 kg/m(2)) were included in the study. Total ghrelin levels were significantly increased in patients with chronic renal failure (CRF) (p < 0.0001). Total ghrelin in CRF correlated positively with active ghrelin (p < 0.001), GH (p < 0.05), IGF-I (p < 0.05), free IGF-I (p = 0.0001), IGFBP-3 (p < 0.01), IGFBP-2 and -6 (p < 0.05). Active ghrelin in CRF correlated positively with IGF-I (p < 0.001), free-IGF-I (p < 0.005), IGFBP-2 (p < 0.05) and IGFBP-3 (p < 0.05). However, most of the correlation were markedly reduced and the significance disappeared after adjustment for different creatinine levels. Hemodialysis in patients with end stage renal disease (ESRD) resulted in a significant reduction of plasma total and active ghrelin (p < 0.01 and p < 0.001 respectively). In conclusion we demonstrated elevated plasma levels of total ghrelin in CRF, and a reduction of total and active ghrelin after a single course of hemodialysis in ESRD. The elevation of ghrelin levels could be caused by impaired clearance and/or metabolism of ghrelin in the kidney. We did not prove clearly significant relationship between ghrelin serum levels and parameters of GH/IGF-I axis in study subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198134     DOI: 10.1016/j.ghir.2005.07.004

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  13 in total

1.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

2.  Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease.

Authors:  Maria Fernanda Soares Naufel; Milena Bordon; Talita Marques de Aquino; Eliane Beraldi Ribeiro; João Tomás de Abreu Carvalhaes
Journal:  Pediatr Nephrol       Date:  2010-08-24       Impact factor: 3.714

3.  Intrarenal ghrelin infusion stimulates distal nephron-dependent sodium reabsorption in normal rats.

Authors:  Brandon A Kemp; Nancy L Howell; Jasmine T Gray; Susanna R Keller; Ralf M Nass; Shetal H Padia
Journal:  Hypertension       Date:  2011-01-10       Impact factor: 10.190

4.  Association of plasma des-acyl ghrelin levels with CKD.

Authors:  Rohit K Gupta; Tamil Kuppusamy; James T Patrie; Bruce Gaylinn; Jianhua Liu; Michael O Thorner; Warren K Bolton
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

Review 5.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 6.  Ghrelin and cachexia in chronic kidney disease.

Authors:  Hajime Suzuki; Akihiro Asakawa; Haruka Amitani; Norifumi Nakamura; Akio Inui
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

7.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

8.  The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects.

Authors:  Jenny Tong; Nimita Dave; Ganesh M Mugundu; Harold W Davis; Bruce D Gaylinn; Michael O Thorner; Matthias H Tschöp; David D'Alessio; Pankaj B Desai
Journal:  Eur J Endocrinol       Date:  2013-05-02       Impact factor: 6.664

9.  Unacylated ghrelin and obestatin: promising biomarkers of protein energy wasting in children with chronic kidney disease.

Authors:  Alice Monzani; Michela Perrone; Flavia Prodam; Stefania Moia; Giulia Genoni; Sara Testa; Fabio Paglialonga; Anna Rapa; Gianni Bona; Giovanni Montini; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2017-11-18       Impact factor: 3.714

10.  Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy.

Authors:  Bas Brouwers; Vincent P E G Pruniau; Elisa J G Cauwelier; Frans Schuit; Evelyne Lerut; Nadine Ectors; Jeroen Declercq; John W M Creemers
Journal:  J Biol Chem       Date:  2013-08-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.